Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.
Vitamin D is an important immune system regulator. The active form of vitamin D, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], has been shown to inhibit the development of autoimmune diseases, including inflammatory bowel disease (IBD). Paradoxically, other immune system-mediated diseases (experimental asthma) and immunity to infectious organisms were unaffected by 1,25(OH)2D3 treatment. There are similar paradoxical effects of vitamin D deficiency on various immune system functions. Vitamin D and vitamin D receptor (VDR) deficiency resulted in accelerated IBD. Experimental asthma was unaffected by 1,25(OH)2D3 treatment and was less severe among VDR-deficient mice. Vitamin D is a selective regulator of the immune system, and the outcome of 1,25(OH)2D3 treatment, vitamin D deficiency, or VDR deficiency depends on the nature of the immune response (eg, infectious disease, asthma, or autoimmune disease). An additional factor that determines the effect of vitamin D status on immune function is dietary calcium. Dietary calcium has independent effects on IBD severity. Vitamin D-deficient mice on low-calcium diets developed the most severe IBD, and 1,25(OH)2D3 treatment of mice on low-calcium diets improved IBD symptoms. However, the best results for IBD were observed when the calcium concentration was high and 1,25(OH)2D3 was administered. Both the type of immune response and the calcium status of the host determine the effects of vitamin D status and 1,25(OH)2D3 on immunity.
Cantorna
Margherita T
MT
Department of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA. mxc69@psu.edu
Zhu
Yan
Y
Froicu
Monica
M
Wittke
Anja
A
D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology / Q000378:metabolism; D002117:Calcitriol / Q000008:administration & dosage / Q000172:deficiency* / Q000502:physiology*; D002118:Calcium / Q000172:deficiency / Q000378:metabolism*; D002120:Calcium Channel Agonists; D003141:Communicable Diseases / Q000188:drug therapy / Q000276:immunology; D006304:Health Status; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000209:etiology / Q000276:immunology*; D051379:Mice; D018167:Receptors, Calcitriol / Q000172:deficiency* / Q000276:immunology / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014807:Vitamin D / Q000008:administration & dosage / Q000276:immunology; D014808:Vitamin D Deficiency / Q000150:complications / Q000276:immunology* / Q000378:metabolism
D002120:Calcium Channel Agonists; D018167:Receptors, Calcitriol; D014807:Vitamin D; D002117:Calcitriol; D002118:Calcium